retatrutide fat loss results The next big shift in obesity care may not be surgery — it may be a weekly shot. Retatrutide, an investigational triple-action medicine, showed 28.3% average body-weight over 80 weeks in Retatrutide Mechanism, Clinical Results and

Medically supervised weight loss means we are with you every step of the way

Muniz is in dermatology private practice in So Paulo, Brazil

Long-acting GLP-1 agonists like Retatrutide amplify and extend this signaling, producing sustained appetite suppression that enables significant weight loss

Secondly, efficacy is the core criterion for evaluating drugs, and currently, multi-target GLP-1 drugs have shown better efficacy

As a result of the clinical trial, the average weight loss rate of the 12 mg administration group was 28.3% as of 80 weeks

Side effect profile by dose Gastrointestinal side effects were the most common adverse events and were clearly dose-related